Terms: = Germ cell tumor AND PR, PGR, progesterone receptor AND Prognosis
176 results:
1. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
[TBL] [Abstract] [Full Text] [Related]
2. Visual and whole-body quantitative analyses of
Hotta M; Sonni I; Thin P; Nguyen K; Gardner L; Ciuca L; Hayrapetian A; Lewis M; Lubin D; Allen-Auerbach M
Ann Nucl Med; 2024 Apr; 38(4):296-304. PubMed ID: 38252228
[TBL] [Abstract] [Full Text] [Related]
3. Radiogenomic landscape: Assessment of specific phagocytosis regulators in lower-grade gliomas.
Maimaiti A; Abulaiti A; Tang B; Dilixiati Y; Li X; Yakufu S; Wang Y; Jiang L; Shao H
Exp Biol Med (Maywood); 2023 Dec; 248(23):2289-2303. PubMed ID: 38062999
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic factors for intermediate- or high-risk neuroblastomas in children in China.
Zhang Y; Zhang WL; Huang DS; Wang YZ; Hu HM; Zhi T; Mei YY
BMC Pediatr; 2023 Dec; 23(1):617. PubMed ID: 38053080
[TBL] [Abstract] [Full Text] [Related]
5. Association between post-operative hPG
Doucet L; Cailleteau A; Vaugier L; Gourmelon C; Bureau M; Salaud C; Roualdes V; Samarut E; Aumont M; Zenatri M; Loussouarn D; Quillien V; Bocquet F; Payen-Gay L; Joubert D; Prieur A; Robert M; Frenel JS
ESMO Open; 2023 Oct; 8(5):101626. PubMed ID: 37713930
[TBL] [Abstract] [Full Text] [Related]
6. Improving outcomes in carcinoid heart disease - learning from a single centre.
Cope J; Maclean R; Hota S; Ramage JK; Mullholland N; Clement D; Brown S; Piper S; MaCarthy P; Wendler O; Srirajaskanthan R
Nucl Med Commun; 2023 Nov; 44(11):968-976. PubMed ID: 37661777
[TBL] [Abstract] [Full Text] [Related]
7. Consolidative radiation in partial responders/unresectable/recurrent disease after first-line/salvage chemotherapy in poor-risk nonseminomatous germ cell tumor prolongs survival: A new paradigm?
Tiwari S; Agrawal S
J Cancer Res Ther; 2023; 19(2):457-460. PubMed ID: 37313917
[TBL] [Abstract] [Full Text] [Related]
8. A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibition.
Buchbinder EI; Giobbie-Hurder A; Ott PA
Invest New Drugs; 2023 Jun; 41(3):365-370. PubMed ID: 37097370
[TBL] [Abstract] [Full Text] [Related]
9. Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer.
Koukourakis IM; Giakzidis AG; Koukourakis MI
Clin Transl Oncol; 2023 Oct; 25(10):3032-3041. PubMed ID: 37059932
[TBL] [Abstract] [Full Text] [Related]
10. A case report of small cell ovarian neuroendocrine carcinoma combined with immunochemotherapy.
Zhu YX; Gao XP; Xin L; Jia YC
Medicine (Baltimore); 2022 Nov; 101(46):e31445. PubMed ID: 36401483
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic primary breast neuroendocrine neoplasms: a case series.
Batty K; Taylor AM; Bernard EJ; Diakos CI; Clarke SJ; Guminski A; Baron-Hay S; Boyle F; Pavlakis N; Chan DL
Intern Med J; 2023 Oct; 53(10):1813-1818. PubMed ID: 36314732
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of the Outcome of Treatment of Brain Metastases from Malignant Trophoblastic Tumours and Risk Factors for prognosis during Pregnancy.
Wang A; Zhang H
Contrast Media Mol Imaging; 2022; 2022():3932460. PubMed ID: 36017013
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic significance of different degrees of resection of skull base chordoma.
Wang Y; Peng Z; Wang Y; Fan R; Zhang H; Jiang W
Clin Transl Oncol; 2022 Dec; 24(12):2441-2452. PubMed ID: 35953670
[TBL] [Abstract] [Full Text] [Related]
14. Diet quality is associated with primary melanoma thickness.
Hughes MCB; Malt M; Khosrotehrani K; Smithers BM; Green AC
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1745-1750. PubMed ID: 35462440
[TBL] [Abstract] [Full Text] [Related]
15. Sexual Dimorphism in Small-intestinal Neuroendocrine tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Oudijk L; de Herder WW; Hofland LJ; Feelders RA
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1969-e1975. PubMed ID: 34999838
[TBL] [Abstract] [Full Text] [Related]
16. Post-recurrence survival in patients with cervical cancer.
Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
[TBL] [Abstract] [Full Text] [Related]
17. PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite prognosis in Prostate Cancers.
Yang M; Li JC; Tao C; Wu S; Liu B; Shu Q; Li B; Zhu R
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572596
[TBL] [Abstract] [Full Text] [Related]
18. Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006.
Hamid O; Robert C; Daud A; Carlino MS; Mitchell TC; Hersey P; Schachter J; Long GV; Hodi FS; Wolchok JD; Arance A; Grob JJ; Joshua AM; Weber JS; Mortier L; Jensen E; Diede SJ; Moreno BH; Ribas A
Eur J Cancer; 2021 Nov; 157():391-402. PubMed ID: 34571336
[TBL] [Abstract] [Full Text] [Related]
19. Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.
Saito Y; Urashima M; Takahashi Y; Ogawa A; Kiyotani C; Yuza Y; Koh K; Watanabe K; Kosaka Y; Goto H; Kikuta A; Okada K; Koga Y; Fujimura J; Inoue M; Sato A; Atsuta Y; Matsumoto K
Bone Marrow Transplant; 2021 Sep; 56(9):2173-2182. PubMed ID: 33911201
[TBL] [Abstract] [Full Text] [Related]
20. Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
Mulder EEAP; de Joode K; Litière S; Ten Tije AJ; Suijkerbuijk KPM; Boers-Sonderen MJ; Hospers GAP; de Groot JWB; van den Eertwegh AJM; Aarts MJB; Piersma D; van Rijn RS; Kapiteijn E; Vreugdenhil G; van den Berkmortel FWPJ; Hoop EO; Franken MG; Ryll B; Rutkowski P; Sleijfer S; Haanen JBAG; van der Veldt AAM
BMC Cancer; 2021 Mar; 21(1):323. PubMed ID: 33765967
[TBL] [Abstract] [Full Text] [Related]
[Next]
